• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰甲癣的患病率。

The prevalence of onychomycosis in Finland.

作者信息

Heikkilä H, Stubb S

机构信息

Department of Dermatology and Venereology, Helsinki University Central Hospital, Finland.

出版信息

Br J Dermatol. 1995 Nov;133(5):699-703. doi: 10.1111/j.1365-2133.1995.tb02741.x.

DOI:10.1111/j.1365-2133.1995.tb02741.x
PMID:8555019
Abstract

Few studies have been made of the prevalence of onychomycosis among ordinary people. We therefore investigated 800 people aged between 6 and 80 years, in different age groups. We found 162 persons in whom onychomycosis was clinically suspected. However, only the 91, in whom the fungal culture was positive for dermatophytic fungi, were included in the final prevalence numbers. We found a prevalence of 13.0% in men, 4.3% in women, and 8.4% in the entire population including children. Onychomycosis was not found in any of the 200 people aged less than 20 years. The prevalences found in this study are much higher than those reported in the earlier studies made elsewhere in Europe.

摘要

针对普通人群中甲癣患病率的研究较少。因此,我们对800名年龄在6至80岁之间的不同年龄组人群进行了调查。我们发现有162人临床上疑似患有甲癣。然而,最终患病率数据仅纳入了91名皮肤癣菌真菌培养呈阳性的患者。我们发现男性患病率为13.0%,女性为4.3%,包括儿童在内的整个人口患病率为8.4%。在200名年龄小于20岁的人群中未发现甲癣病例。本研究中发现的患病率远高于欧洲其他地区早期研究报告的患病率。

相似文献

1
The prevalence of onychomycosis in Finland.芬兰甲癣的患病率。
Br J Dermatol. 1995 Nov;133(5):699-703. doi: 10.1111/j.1365-2133.1995.tb02741.x.
2
Onychomycosis in Icelandic swimmers.冰岛游泳者的甲癣
Acta Derm Venereol. 1999 Sep;79(5):376-7. doi: 10.1080/000155599750010319.
3
[Onychomycosis in Casablanca (Morocco)].[卡萨布兰卡(摩洛哥)的甲癣]
J Mycol Med. 2013 Mar;23(1):9-14. doi: 10.1016/j.mycmed.2012.10.002. Epub 2012 Dec 31.
4
Study of onychomycosis in Isfahan, Iran.伊朗伊斯法罕地区甲真菌病的研究。
Mycoses. 2010 Mar 1;53(2):153-7. doi: 10.1111/j.1439-0507.2008.01679.x. Epub 2009 Feb 26.
5
Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study.西班牙皮肤癣菌性甲真菌病的患病率:一项横断面研究。
Br J Dermatol. 1995 May;132(5):758-61. doi: 10.1111/j.1365-2133.1995.tb00722.x.
6
The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.银屑病患者甲癣的患病率、病原体及治疗:一项前瞻性对照试验。
Clin Exp Dermatol. 2007 Jan;32(1):1-5. doi: 10.1111/j.1365-2230.2006.02215.x. Epub 2006 Jul 4.
7
Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey.英国皮肤癣菌性甲真菌病的患病率:一项综合调查结果
Br J Dermatol. 1992 Feb;126 Suppl 39:23-7. doi: 10.1111/j.1365-2133.1992.tb00005.x.
8
Clinical and mycological features of onychomycosis in central Tunisia: a 22 years retrospective study (1986-2007).突尼斯中部甲真菌病的临床和真菌学特征:一项 22 年回顾性研究(1986-2007 年)。
Mycoses. 2013 May;56(3):273-80. doi: 10.1111/myc.12016. Epub 2012 Oct 25.
9
Onychomycosis: clinical pattern and prevailing fungi in Kathmandu.甲癣:加德满都的临床模式及主要真菌
Nepal Med Coll J. 2011 Sep;13(3):193-6.
10
The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' offices.在加拿大一个多中心的、有30000名患者前往医生办公室就诊的样本中,未被怀疑的甲真菌病及其致病生物体的患病率。
J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1567-72. doi: 10.1111/jdv.13677. Epub 2016 May 11.

引用本文的文献

1
Efficacy of Topical Antifungal Nail Solution Versus Topical Placebo Solution for the Treatment of Pedal Onychomycosis: A Randomized Controlled Trial.外用抗真菌指甲溶液与外用安慰剂溶液治疗足癣甲真菌病的疗效:一项随机对照试验
Infect Dis Ther. 2025 May 25. doi: 10.1007/s40121-025-01165-8.
2
Pediatric dermatophyte onychomycosis: a review.儿童皮肤癣菌性甲真菌病综述
Int J Dermatol. 2025 Mar;64(3):465-472. doi: 10.1111/ijd.17495. Epub 2024 Sep 18.
3
Antidermatophyte activity and PK/PD of ME1111 in a guinea pig model of tinea corporis.
抗真菌活性和 ME1111 在豚鼠体癣模型中的药代动力学/药效学。
J Antibiot (Tokyo). 2024 Aug;77(8):533-539. doi: 10.1038/s41429-024-00738-y. Epub 2024 May 20.
4
Systematic review of the prevalence of onychomycosis in children.儿童甲真菌病患病率的系统评价。
Pediatr Dermatol. 2022 Nov;39(6):855-865. doi: 10.1111/pde.15100. Epub 2022 Sep 21.
5
What can GP data tell us about the treatment of onychomycosis in the UK?英国普通科医疗数据能告诉我们关于甲癣治疗的哪些信息?
Skin Health Dis. 2021 Dec 16;2(1):e84. doi: 10.1002/ski2.84. eCollection 2022 Mar.
6
Biodiversity of mycobial communities in health and onychomycosis.健康和甲真菌病中的丝状真菌群落多样性。
Sci Rep. 2022 May 25;12(1):8872. doi: 10.1038/s41598-022-13074-8.
7
Epidemiological and Mycological Aspects of Onychomycosis in Dakar (Senegal).达喀尔(塞内加尔)甲真菌病的流行病学和真菌学研究
J Fungi (Basel). 2019 Apr 29;5(2):35. doi: 10.3390/jof5020035.
8
The prevalence and etiological factors of onychomycosis in psoriatic patients.银屑病患者甲真菌病的患病率及病因学因素
Postepy Dermatol Alergol. 2018 Jun;35(3):309-313. doi: 10.5114/pdia.2017.68299. Epub 2018 Apr 24.
9
The Dermatologist's Approach to Onychomycosis.皮肤科医生治疗甲癣的方法。
J Fungi (Basel). 2015 Aug 19;1(2):173-184. doi: 10.3390/jof1020173.
10
Onychomycosis: A Review.甲癣:综述
J Fungi (Basel). 2015 Mar 27;1(1):30-43. doi: 10.3390/jof1010030.